Viewing Study NCT01880567

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:37 AM
Ignite Modification Date: 2026-05-31 @ 9:44 AM
Study NCT ID: NCT01880567
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-03
First Post: 2013-06-14
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Ibrutinib and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Older Patients With Newly Diagnosed Mantle Cell Lymphoma
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None CCND1 Positive View
None CCND2 Positive View
None CCND3 Positive View
None CD20 Positive View
None Mantle Cell Lymphoma View
None Recurrent Mantle Cell Lymphoma View
None Refractory Mantle Cell Lymphoma View
Keywords: